Clinical Trial

(De)Prescribing in Hospitalized Sarcopenic Geriatric Patients

Study acronym: MEDEGESARC
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 7, 2023 (before its estimated February 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to compare the effects of a deprescribing pharmacotherapy approach to the STOPP-START approach (usual care) in geriatric patients with sarcopenia and polypharmacy. The main question it aims to answer is the number and type of medication that can be stopped in this population without being restarted within 6 months. After inclusion a medication review is performed by a team consisting of the researcher, a geriatrician and a hospital pharmacist, according to the protocol within which the patient was randomised. Participants are follow up at appointments after 1, 3 and 6 months. At these appointments, questionnaires are administered about the quality of life and complications related to medication.
Trial Details
NCT Number NCT05757765
Lead Sponsor Zuyderland Medisch Centrum
Conditions Sarcopenia
Enrollment 160 participants
Start Date 2023-02-27
Primary Completion 2025-02 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2023-03-07